Sword Diagnostics
Sword Diagnostics is a privately held life sciences company founded in 2004 in Carmel, Indiana, that states it serves the research, pharmaceutical, and clinical communities with diagnostics-related offerings, though no products, revenue, or active operations are currently documented.
- Company typePrivate
- Founded2004
- HeadquartersCarmel, United States
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What Sword Diagnostics does
Sword Diagnostics is a privately held, for-profit life sciences company founded in 2004 and based in Carmel, Indiana. According to its firmographic record, the company addresses the needs of the research, pharmaceutical, and clinical communities, positioning it as a supplier of diagnostics-related products or services to academic, industrial, and healthcare laboratory end markets. The company is led by David Dingott, who serves as President and CEO, and Rob Donoho, who serves as Vice President of Sales and Marketing.
Over a roughly 12-year active funding window (2005\u20132017), Sword Diagnostics raised approximately $5.45M across at least eight disclosed rounds, with early backing from Jumpstart New Jersey Angel Network and NJTC Venture Fund, a later Keiretsu Forum Northwest engagement, and a final reported event involving Avant Global LLC. No products, technology stack, pricing, customer roster, or revenue figures are documented in the available input data. The company\u2019s business model is therefore not directly inferable beyond the inference that it monetizes some form of diagnostic offering to research and clinical buyers.
The company is currently very small (1\u201310 employees) and shows material signs of operational stress: no funding has been disclosed since 2017, and its primary web domain, sworddiagnostics.com, is listed for sale on the HugeDomains marketplace at $9,695. This combination of thin public footprint, long funding gap, and lapsed domain raises serious questions about ongoing commercial activity and the durability of any revenue stream.
Sword Diagnostics firmographics
Firmographics- Name
- Sword Diagnostics
- Website
- https://sworddiagnostics.com
- Company type
- Private
- Founded year
- 2004
- Headcount range
- 1–10 employees
- Short description
- Sword Diagnostics is a privately held life sciences company founded in 2004 in Carmel, Indiana, that states it serves the research, pharmaceutical, and clinical communities with diagnostics-related offerings, though no products, revenue, or active operations are currently documented.
- Ownership category
- akta.pro rank
Where Sword Diagnostics is headquartered
LocationHeadquarters
- HQ city
- Carmel
- HQ country
- United States
- HQ region
- North America
Markets served
Sword Diagnostics business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales
Sword Diagnostics product offering
Product offeringCore offering
Sword Diagnostics is a life sciences company that develops products to address the needs of the research, pharmaceutical, and clinical communities. The company is privately held, headquartered in Carmel, United States, and was founded in 2004. Specific product lines, technologies, and applications are not detailed in the available source material.
Product overview
No product or service information available. The source data is a domain marketplace listing (HugeDomains) for the sale of the domain name SwordDiagnostics.com, not an actual company website or product page. No details about Sword Diagnostics' products, services, or technology offerings are present in the provided source.
Differentiator
Problem solved
Functional benefit
Companies that use Sword Diagnostics
Customer profileIdeal customer profiles1 record
Sword Diagnostics technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Sword Diagnostics partnerships and signals
Strategic signalRecent moves6 records
Expansion highlights3 records
Sword Diagnostics competitors and assessment
Company assessmentDirect peers
- Bio-Rad Laboratories: Bio-Rad is a global life sciences and clinical diagnostics company that supplies instruments, reagents, and consumables to research, pharmaceutical, and clinical customers — directly comparable to the customer segments and product scope implied by Sword Diagnostics' positioning.
- Hologic: Hologic's diagnostic division develops molecular and immunoassay products for clinical and research laboratories, providing a clear analog for a diagnostics company serving clinical customers.
- Cepheid (Danaher): Cepheid, a Danaher subsidiary, develops molecular diagnostic systems and tests for clinical and research use, with a focus on integrated sample-to-answer platforms, comparable in function to a small diagnostics company targeting clinical customers.
- GenMark Diagnostics (Roche): GenMark, now part of Roche, develops molecular diagnostic tests for clinical laboratories, a directly comparable peer in the IVD market serving clinical customers with diagnostic products.
- QuidelOrtho: QuidelOrtho develops and markets immunoassay and molecular diagnostic tests for clinical and research use, making it a directly comparable peer in the IVD space with overlapping customer bases.
Broad incumbents
- Roche Diagnostics: Roche Diagnostics is a global incumbent in in-vitro diagnostics, providing a full suite of instruments, reagents, and laboratory services across clinical and research segments, a clear market leader analog.
- Siemens Healthineers: Siemens Healthineers operates a broad diagnostics portfolio including immunoassays, clinical chemistry, and molecular diagnostics, making it a relevant incumbent peer in the clinical and research diagnostics market.
- Becton, Dickinson and Company (BD): BD is a broad medical technology incumbent with substantial life sciences and diagnostic offerings, including instruments, reagents, and consumables for clinical and research labs, providing a relevant incumbent benchmark.
- Abbott Diagnostics: Abbott operates a broad diagnostics division spanning immunoassays, molecular diagnostics, and point-of-care tests, serving the same research, pharma, and clinical customer base targeted by Sword Diagnostics.
Emerging players
- Mesa Labs: Mesa Labs is a smaller life sciences tools and diagnostics company that has grown through niche acquisitions of analytical instruments and consumables, providing a size-comparable analog for a small diagnostics company in the life sciences space.
Market position
Strengths2 records
Weaknesses3 records
Competitive moat1 record
Key risks4 records
Key highlights4 records
Customer concentration
Sword Diagnostics social profiles
Digital presenceSword Diagnostics financial estimates
Financial estimateRevenue estimate
Valuation estimate
Sword Diagnostics leadership team
Management profileNumber of profiles
Profiles2 records
Sword Diagnostics funding detail
Funding detailFunding overview
Funding rounds8 records
Investors4 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Sword Diagnostics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Sword Diagnostics
What does Sword Diagnostics do?
Sword Diagnostics is a life sciences company that develops products to address the needs of the research, pharmaceutical, and clinical communities. The company is privately held, headquartered in Carmel, United States, and was founded in 2004. Specific product lines, technologies, and applications are not detailed in the available source material.
When was Sword Diagnostics founded?
Sword Diagnostics was founded in 2004. It employs 1 to 10 people.
Where is Sword Diagnostics based?
Sword Diagnostics is headquartered in Carmel, United States, in the North America region.
Who are Sword Diagnostics's main competitors?
Direct peers on record are Bio-Rad Laboratories, Hologic, Cepheid (Danaher), GenMark Diagnostics (Roche) and QuidelOrtho. Broad incumbents are Roche Diagnostics, Siemens Healthineers, Becton, Dickinson and Company (BD) and Abbott Diagnostics. Mesa Labs is listed as an emerging player.
Does Sword Diagnostics have an API?
No public API is recorded for Sword Diagnostics.